伍尔沃迪尼亚治疗研究峰会的执行总结

Jill M Krapf1, Paul J Yong, Marlene D Berke

  • 1Center for Vulvovaginal Disorders Florida, Tampa, Florida; the Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; the Department of Psychology, Yale University, New Haven, Connecticut; the Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachussets; the Division of Obstetrics and Gynecology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden; the Department of Obstetrics and Gynecology, Galilee Medical Center and Bar-Ilan University Faculty of Medicine, Nahariya, Israel; the Department of Pharmacology and Physiology and the Department of Obstetrics and Gynecology, University of Rochester, Rochester, the AIM Center for Personalized Medicine, Purchase, and the Centers for Vulvovaginal Disorders, New York, New York; San Diego Sexual Medicine, San Diego, California; the Department of Perioperative Medicine, Clinical Center/National Institutes of Health, Bethesda, Maryland; the Center for Pelvic Medicine and Drexel University College of Medicine, Philadelphia, Pennsylvania; Innovative Pain Care, Marietta, Georgia; and the Department of Obstetrics and Gynecology, George Washinton University, Washington, DC.

Obstetrics and gynecology
|November 6, 2025
PubMed
概括

研究人员确定了诱发性阴道的有希望的新疗法,重点关注不那么侵入性的选择. 顶级候选人包括巨细胞稳定剂和神经向药物,以解决神经炎症.